An orally available Cav 2.2 calcium channel inhibitor for the treatment of neuropathic pain.
Kutzsche J, Guzman GA, Willuweit A, Kletke O, Wollert E, Gering I, Jürgens D, Breitkreutz J, Stark H, Beck-Sickinger AG, Klöcker N, Hidalgo P, Willbold D.
Kutzsche J, et al. Among authors: hidalgo p.
Br J Pharmacol. 2023 Dec 29. doi: 10.1111/bph.16309. Online ahead of print.
Br J Pharmacol. 2023.
PMID: 38157867